Lenacapavir: A New Hope in HIV Prevention Under Priority Review
Gilead Sciences, a well-known pharmaceutical company, has developed a new medicine called lenacapavir, which is being reviewed under the priority approval process by the U.S. Food and Drug Administration (FDA). If approved, this drug could revolutionize HIV prevention by offering…